MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma

Genes Chromosomes and Cancer

Volumn 28, Issue 1, 2000, Pages 58-65

  Debelenko, Larisa V ^a   Swalwell, Jennifer I ^a   Kelley, Michael J ^b   Brambilla, Elisabeth ^c   Manickam, Pachiappan ^d   Baibakov, Galina ^a   Agarwal, Sunita K ^e   Spiegel, Allen M ^e   Marx, Stephen J ^e   Chandrasekharappa, Settara C ^d   Collins, Francis S ^d   Travis, William D ^f   Emmert Buck, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE DELETION; GENE INACTIVATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC SCREENING; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOMA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL;

CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CHROMOSOMES, HUMAN, PAIR 11; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 6744248624     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200005)28:1<58::AID-GCC7>3.0.CO;2-2     Document Type: Article

References (37)

1. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR, Skarulis MC, Doppman JL, Kim YS, Lubensky IA, Zhuang Z, Green JS, Boguski MS, Weisemann J, Green J, Guru SC, Manickam P, Olufemi S-E, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ. 1997. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 6:1169-1175.
2. Agarwal SK, Debelenko LV, Rester MB, Guru AC, Manickam P, Olufemi S-E, Skarulis MC, Heppner C, Crabtree JS, Lubensky IA, Zhuang Z, Kim YS, Chandrasekharappa SC, Collins FS, Liotta LA, Spiegel AM, Burns AL, Emmert-Buck MR, Marx SJ. 1998. Analysis of recurrent germline mutations in the MEN1 gene encounted in apparently unrelated families. Human Mutations 12: 75-82.
3. Bassett JH, Forbes SA, Pannett AA, Lloyd SE, Christie PT, Wooding C, Harding B, Besser GM, Edwards CR, Monson JP, Sampson J, Wass JA, Wheeler MH, Thakker RV. 1998. Characterization of mutations in patients with multiple endocrineneoplasia type 1. Am J Hum Genet 62:232-244.
4. Brambilla E, Negoescu A, Gazzeri S, Lantuejoul S, Moro D, Brambilla C, Coll JL. 1996. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 149:1941-1952.
5. Caligo MA, Ghimenti C, Marchetti A, Lonobile A, Buttitta F, Pellegrini S, Bevilacqua G. 1998. Microsatellite alterations and p53, TGFβRII, IGFIIR, and BAX mutations in sporadic non-small-cell lung cancer. Int J Cancer 78:606-609.
6. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S-E, Collins FS, Emmert-Buck MR, Debelenko LA, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ. 1997. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404-407.
7. Colby TV, Koss MN, Travis WD. 1995. Tumors of the Lower Respiratory Tract. Washington, DC: Armed Forces Institute of Pathology.
8. Courseaux A, Grosgeorge J, Gaudray P, Pannett AAJ, Forbes SA, Williamson C, Bassett D, Thakker RV, Teh BT, Farnebo F, Shepherd J, Skogseid B, Larsson C, Giraud S, Zhang CX, Salandre J, Calender A. 1996. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. Genomics 37:354-365.
9. Debelenko LV, Emmert-Buck MR, Manickam P, Guru SC, Kester MB, DiFranco EM, Olufemi S-E, Agarwal S, Lubensky IA, Zhuang Z, Burns AL, Spiegel AM, Liotta LA, Collins FS, Marx SJ, Chandrasekharappa SC. 1997a. Haplotype analysis defines a minimal interval for multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res 57:1039-1042.
10. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, Lubensky IA, Zhuang Z, Guru SC, Manickam P, Olufemi S-E, Chandrasekharappa SC, Crabtree JS, Kim YS, Heppner C, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Collins FS, Travis WD, Emmert-Buck MR. 1997b. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6:2285-2290.
11. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. 1996. Laser capture microdissection. Science 274:998-1001.
12. Emmert-Buck MR, Lubensky IA, Dong Q, Manickam P, Guru SC, Kester MB, Olufemi S-E, Agarwal S, Burns AL, Spiegel AM, Collins FS, Marx SJ, Zhuang Z, Liotta LA, Chandrasekharappa S, Debelenko LV. 1997. Localization of the multiple endocrine neoplasia type 1 (MEN1) gene based on tumor LOH analysis. Cancer Res 57:1855-1858.
13. Glisin V, Crkvenjakov R, Byus C. 1974. Ribonucleic acid isolated by cesium chloride centrifugation. Biochemistry 13:2633-2637.
14. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid, AL, Brambilla C. 1994. Loss of heterozygosity at the Rb locus correlates with loss of Rb protein in primary malignant neuroendocrine lung carcinomas. Int J Cancer 58:818-824.
15. Guru SC, Agarwal SK, Manickam P, Olufemi S-E, Crabtree JS, Weisemann JM, Kester MB, Kim YS, Wamg Y, Emmert-Buck MR, Liotta LA, Spiegel AM, Boguski MS, Roe BA, Collins FS, Marx SJ, Burns L, Chandrasekharappa SC. 1997. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res 7:725-735.
16. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ. 1988. Abnormalities in structure and expression of the human retinoblastoma gene in small cell lung cancer. Science 241:353-357.
17. Hencel CH, Hsieh CL, Gazdar AF, Johnson BE, Sakaguchi AY, Naylor SL, Lee WA, Lee EY. 1990. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res 50:1067-1072.
18. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi S-E, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins, FS, Spiegel AM, Burns AL, Marx SJ. 1997. Somatic mutation of the MEN1 gene in sporadic parathyroid tumours. Nat Genet 16:375-378.
19. Hessman O, Lindberg D, Skogseid B, Carling T, Hellman P, Rastad J, Akerstrom G, Westin G. 1998. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial malignant tumors of the endocrine pancreas. Cancer Res 58:377-379.
20. Hurr K, Kemp B, Silver SA, el-Naggar AK. 1996. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance. Am J Pathol 149:615-620.
21. Iannuzzi MC, Toews GB. 1994. Neoplasms of the king. In Stein JH, editor. Internal medicine. St. Louis: Mosby. p 1733-1741.
22. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjl̈d M. 1988. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85-87.
23. Levin NA, Brzoska PM, Warnock ML, Gray JW, Christman MF. 1995. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer 13:175-185.
24. Lohmann DR, Fesseler B, Putz B, Reich U, Bohm J, Prauer H, Wunsch PH, Hofler H. 1993. Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Res 53:5797-5801.
25. Manickam P, Guru SC, Debelenko LV, Agarwal S, Olufemi S-E, Weisemann J, Boguski MS, Crabtree JS, Wang Y, Roe BA, Lubensky IA, Zhuang Z, Kester MB, Burns AL, Spiegel AM, Marx SJ, Liotta LA, Emmert-Buck MR, Collins FS, Chandrasekharappa SC. 1997. Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region. Hum Genet 101:102-108.
26. Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, Hasleton P, Gazdar AF. 1999. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 85:600-6077.
27. Phelps RM, Johnson BE, Ihde DC, Gazdar AK, Carbone DP, McClintock PR, Linnoila I, Matthews MJ, Bunn PA, Carney D, Minna JD, Mulshine JL. 1996. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem 24(Suppl):32-91.
28. Przygodzki RM, Finkelstein SD, Langer JC, Swalsky PA, Fishback N, Bakker A, Guinee DG, Koss M, Travis WD. 1996. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors: correlation with histological subtype and clinical outcome. Am J Pathol 148:1531-1541.
29. Pylkkänen L, Karjalainen A, Anttila S, Vainio H, Husgafvel-Pursiainen K. 1997. No evidence of microsatellite instability but frequent loss of heterozygosity in primary resected lung cancer. Envir Mol Mutagen 3Q:217-223.
30. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schrc̈k E, du Manoir S, Cremer T. 1994. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54:1801-1806.
31. Roncalli M, Doglioni C, Springall DR, Papotti M, Pagani A, Polak JM, Ibrahim NB, Coggi G, Viale G. 1992. Abnormal p53 expression in lung neuroendocrine tumors: diagnostic and prognostic implications. Diagn Mol Pathol 1:129-135.
32. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Culter GB, Nieman L, Chrousos G, Pass H, Doppman J. 1991. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 15:529-553.
33. Travis WD, Rush W, Flieder DB, Falk R, Fleming MV, Gal AA, Koss MN. 1998. Survival analysis of 200 pulmonary neuroendocrine tumors: with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 22:934-944.
34. Wang EH, Ebrahimi SA, Wu AY, Kashefi C, Passaro E Jr, Sawicki MP. 1998. Mutation of the MENIN gene in sporadic pancreatic-endocrine tumors. Cancer Res 58:4417-1420.
35. Walch AK, Zitzelsberger HK, Aubele MM, Mattis AE, Bauchinger M, Candidus S, Prauer HW, Werner M, Hofler H. 1998. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Am J Pathol 153:1089-1098.
36. Zhuang Z, Vortmayer AO, Pack S, Huang S, Pham TA, Wang C, Park W-S, Agarwal, SK, Debelenko LV, Kester MB, Guru SC, Manickam P, Olufemi S-E, Yu F, Heppner C, Crabtree JS, Skarulis MC, Venzon DJ, Emmert-Buck MR, Spiegel AM, Chandrasekharappa SC, Collins FS, Burns AL, Marx SJ, Jensen RT, Liotta LA, Lubensky IA. 1997a. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57:4682-4686
37. Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park W-S, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi S-E, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL, Lubensky IA. 1997b. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res 57:5446-5451.